⌘K

Login Start Free

Home/Filings/4/0001104659-20-073825

4//SEC Filing

KRANZLER JAY D 4

Accession 0001104659-20-073825

CIK 0001644963other

View on SEC.gov Company Profile

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 5:09 PM ET

Size

4.9 KB

Accession

0001104659-20-073825

Insider Transaction Report

Form 4

Period: 2020-06-16

AVENUE THERAPEUTICS, INC.ATXI

Director

Transactions

Award
Common Stock
2020-06-16+10,000→ 84,663 total

Footnotes (2)

[F1]Common Stock vests upon the earliest to occur of the following: (i) Grantee's death or disability; (ii) a change in control of Avenue Therapeutics, Inc.; or (iii) the Second Stage Closing with InvaGen.
[F2]Includes 84,663 shares of restricted stock.

Documents

1 file

4
tm2022744d2_form4.xmlPrimary
FORM 4

Issuer

AVENUE THERAPEUTICS, INC.

CIK 0001644963

Entity typeother

Related Parties

1

filerCIK 0001055666

Filing Metadata

Form type: 4
Filed: Jun 15, 8:00 PM ET
Accepted: Jun 16, 5:09 PM ET
Size: 4.9 KB

View on SEC.gov